Impact of different therapies on the survival of patients with stage I-IIA cervical cancer with intermediate risk factors.

ABSTRACT:

Background

The aim of this study was to determine the effects of different therapies on patients with cervical cancer (CC) with intermediate risk factors.

Methods

Clinicopathological data of 596 patients diagnosed with stage I-IIA CC at the Obstetrics and Gynecology Hospital of Fudan University between January 2013 and November 2015 were retrospectively reviewed. Of the patients, 500 patients received adjuvant therapy including chemotherapy (CT), radiotherapy (RT), and sequential chemotherapy and radiotherapy (CT + RT). Patients who displayed at least one intermediate risk factor number were screened.

Results

The median follow-up was 62 months. The 5-year progression-free survival (PFS) and overall survival (OS) of the entire cohort were 90.4% and 90.9%, respectively.

SUBMITTER: Nie J 

PROVIDER: S-EPMC7867952 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature